Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21,797 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of quadrivalent human papillomavirus vaccine against persistent infection and genital disease in Chinese women: A randomized, placebo-controlled trial with 78-month follow-up.
Wei L, Xie X, Liu J, Zhao Y, Chen W, Zhao C, Wang S, Liao X, Shou Q, Qiu Y, Qiao Y, Saah AJ. Wei L, et al. Among authors: zhao y, zhao c. Vaccine. 2019 Jun 12;37(27):3617-3624. doi: 10.1016/j.vaccine.2018.08.009. Epub 2018 Aug 16. Vaccine. 2019. PMID: 30122646 Clinical Trial.
Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90 months of follow-up.
Chen W, Zhao Y, Xie X, Liu J, Li J, Zhao C, Wang S, Liao X, Shou Q, Zheng M, Saah AJ, Wei L, Qiao Y. Chen W, et al. Among authors: zhao y, zhao c. Vaccine. 2019 Feb 4;37(6):889-897. doi: 10.1016/j.vaccine.2018.12.030. Epub 2019 Jan 9. Vaccine. 2019. PMID: 30638797 Clinical Trial.
Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial.
Qiao YL, Wu T, Li RC, Hu YM, Wei LH, Li CG, Chen W, Huang SJ, Zhao FH, Li MQ, Pan QJ, Zhang X, Li Q, Hong Y, Zhao C, Zhang WH, Li YP, Chu K, Li M, Jiang YF, Li J, Zhao H, Lin ZJ, Cui XL, Liu WY, Li CH, Guo DP, Ke LD, Wu X, Tang J, Gao GQ, Li BY, Zhao B, Zheng FX, Dai CH, Guo M, Zhao J, Su YY, Wang JZ, Zhu FC, Li SW, Pan HR, Li YM, Zhang J, Xia NS. Qiao YL, et al. Among authors: zhao j, zhao h, zhao b, zhao c, zhao fh. J Natl Cancer Inst. 2020 Feb 1;112(2):145-153. doi: 10.1093/jnci/djz074. J Natl Cancer Inst. 2020. PMID: 31086947 Free PMC article. Clinical Trial.
An evaluation of solid versus liquid transport media for high-risk HPV detection and cervical cancer screening on self-collected specimens.
Du H, Duan X, Liu Y, Shi B, Zhang W, Wang C, Qu X, Bao J, Li J, Zhao C, Jiang J, Liu J, Wu K, Xiao A, Duan L, Huang X, Bian S, Zhang L, Luo H, Wei L, Belinson JL, Wu R; CHIMUST group. Du H, et al. Among authors: zhao c. Infect Agent Cancer. 2020 Nov 30;15(1):72. doi: 10.1186/s13027-020-00333-4. Infect Agent Cancer. 2020. PMID: 33292341 Free PMC article.
Evaluation of Cobas HPV and SeqHPV Assays in the Chinese Multicenter Screening Trial.
Du H, Duan X, Liu Y, Shi B, Zhang W, Wang C, Qu X, Li J, Zhao C, Liu J, Jiang J, Jin H, Li H, Xiao A, Bao J, Duan L, Huang X, Luo H, Bian S, Zhang L, Wei L, Belinson JL, Wu R. Du H, et al. Among authors: zhao c. J Low Genit Tract Dis. 2021 Jan 1;25(1):22-26. doi: 10.1097/LGT.0000000000000577. J Low Genit Tract Dis. 2021. PMID: 33347045 Clinical Trial.
Elimination of Cervical Cancer: Challenges Promoting the HPV Vaccine in China.
Wei L, Xie X, Liu J, Qiao Y, Zhao F, Wu T, Zhang J, Ma D, Kong B, Chen W, Zhao C, Zhao Y, Li J, Li M, Xia N. Wei L, et al. Among authors: zhao y, zhao f, zhao c. Indian J Gynecol Oncol. 2021;19(3):51. doi: 10.1007/s40944-021-00536-6. Epub 2021 Jun 27. Indian J Gynecol Oncol. 2021. PMID: 34222614 Free PMC article. Review.
21,797 results
You have reached the last available page of results. Please see the User Guide for more information.